You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

PROPOFOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Propofol

A generic version of PROPOFOL was approved as propofol by SAGENT PHARMS INC on January 4th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROPOFOL?
  • What are the global sales for PROPOFOL?
  • What is Average Wholesale Price for PROPOFOL?
Drug patent expirations by year for PROPOFOL
Drug Prices for PROPOFOL

See drug prices for PROPOFOL

Recent Clinical Trials for PROPOFOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityN/A
Assiut UniversityPhase 3

See all PROPOFOL clinical trials

Pharmacology for PROPOFOL
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for PROPOFOL
Anatomical Therapeutic Chemical (ATC) Classes for PROPOFOL

US Patents and Regulatory Information for PROPOFOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal PROPOFOL propofol INJECTABLE;INJECTION 217525-001 Aug 15, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Innopharma PROPOFOL propofol INJECTABLE;INJECTION 205576-001 Sep 16, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys PROPOFOL propofol INJECTABLE;INJECTION 205067-001 Nov 15, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sagent Pharms Inc PROPOFOL propofol INJECTABLE;INJECTION 075102-001 Jan 4, 1999 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aspiro PROPOFOL propofol INJECTABLE;INJECTION 217013-001 Jun 20, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.